Amedisys (AMED) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Fourth Quarter and Year End 2020 Financial Results
February 24, 2021 4:05 PM ESTBATON ROUGE, La., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2020.
Three-Month Periods Ended December 31, 2020 and 2019
Net service revenue increased $50.0Â million to $550.7Â million compared to $500.7Â million in 2019.Net income attributable to Amedisys, Inc. of $45.2Â million compared to $27.7Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $1.36 compared to $0.83 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $78.1Â million compared to $52.2Â million in 2019.Adjusted net service revenue of $550.7Â million compared to $500.7Â million in... More